OBJECTIVE: to evaluate whether oral supplementation with zinc or zinc/arginine increases the antibody response to influenza vaccine or modulates the lymphocyte phenotype in elderly subjects. DESIGN: a randomized controlled trial with two supplemented groups and one control group. SETTING: a community nursing home. PARTICIPANTS: 384 subjects aged 64-100 (mean age 82 years) examined in three separate studies. INTERVENTION: oral supplementation with zinc (400 mg/day) or zinc plus arginine (4 g/day) for 60 days starting 15 days before influenza vaccination. The control groups received vaccine only. MEASUREMENTS: haematological and nutritional indices, antibody titre against influenza viral antigens, lymphocyte phenotype. RESULTS:supplementation with zinc or zinc plus arginine increased zinc plasma concentrations restoring the age-related impairment in zinc concentrations to values found in younger people. The antibody titre against influenza viral antigens was not increased in zinc or zinc/arginine supplemented groups in comparison with subjects receiving vaccine alone. The number of CD3, CD4 or CD8 lymphocytes was not affected by zinc or zinc/arginine supplementation. CONCLUSION: prolonged supplementation with zinc or zinc/arginine restores zinc plasma concentrations but is ineffective in inducing or ameliorating the antibody response after influenza vaccination in elderly subjects.
RCT Entities:
OBJECTIVE: to evaluate whether oral supplementation with zinc or zinc/arginine increases the antibody response to influenza vaccine or modulates the lymphocyte phenotype in elderly subjects. DESIGN: a randomized controlled trial with two supplemented groups and one control group. SETTING: a community nursing home. PARTICIPANTS: 384 subjects aged 64-100 (mean age 82 years) examined in three separate studies. INTERVENTION: oral supplementation with zinc (400 mg/day) or zinc plus arginine (4 g/day) for 60 days starting 15 days before influenza vaccination. The control groups received vaccine only. MEASUREMENTS: haematological and nutritional indices, antibody titre against influenza viral antigens, lymphocyte phenotype. RESULTS: supplementation with zinc or zinc plus arginine increased zinc plasma concentrations restoring the age-related impairment in zinc concentrations to values found in younger people. The antibody titre against influenza viral antigens was not increased in zinc or zinc/arginine supplemented groups in comparison with subjects receiving vaccine alone. The number of CD3, CD4 or CD8 lymphocytes was not affected by zinc or zinc/arginine supplementation. CONCLUSION: prolonged supplementation with zinc or zinc/arginine restores zinc plasma concentrations but is ineffective in inducing or ameliorating the antibody response after influenza vaccination in elderly subjects.
Authors: Eugenio Mocchegiani; Javier Romeo; Marco Malavolta; Laura Costarelli; Robertina Giacconi; Ligia-Esperanza Diaz; Ascension Marcos Journal: Age (Dordr) Date: 2012-01-06
Authors: A Salva; L Coll-Planas; S Bruce; L De Groot; S Andrieu; G Abellan; B Vellas; Sandrine Andrieu; Luisa Bartorelli; Ytshal N Berner; Stuart Bruce; Bruno Corman; Alex Domingo; Thomas P Egger; Lisette de Groot; Yves Guigoz; Ana Imedio; Mercè Planas; Concha Porras; Joan Carles Rovira; Antoni Salvà; José Antonio Serra; Bruno Vellas Journal: J Nutr Health Aging Date: 2009-06 Impact factor: 4.075
Authors: Ata Murat Kaynar; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Krissy K Moehling; Michael Susick; Veli Bakalov; Bruce R Pitt; Daniel J Bain; Ted M Ross; Sean G Saul; Mahlon Raymund; Richard K Zimmerman Journal: Hum Vaccin Immunother Date: 2016-01-11 Impact factor: 3.452
Authors: H K Talbot; L A Coleman; K Crimin; Y Zhu; M T Rock; J Meece; D K Shay; E A Belongia; M R Griffin Journal: Vaccine Date: 2012-04-03 Impact factor: 3.641
Authors: Tom H Karlsen; Halvor Sommerfelt; Skjalg Klomstad; Per Kragh Andersen; Tor A Strand; Rune J Ulvik; Christina Ahrén; Harleen M S Grewal Journal: Infect Immun Date: 2003-07 Impact factor: 3.441
Authors: Esmaeil Mortaz; Gillina Bezemer; Shamila D Alipoor; Mohammad Varahram; Sharon Mumby; Gert Folkerts; Johan Garssen; Ian M Adcock Journal: Front Nutr Date: 2021-07-05